What Happens To The Brain In The Final Moments Before A Plane Crash? Explained
To answer that, News18 spoke to neurologists, psychologists, and trauma specialists who help unpack the biological reality of a high-impact crash—what the brain experiences in the final moments.
Brain-Led Instincts In The Final Seconds
According to experts, as the aircraft begins its uncontrolled descent, the brain activates primitive survival mechanisms, and the human body releases 'adrenaline' due to extreme fear.
'In the final seconds before a high-impact crash, the human body enters a state of extreme stress. Adrenaline is released, heart rate spikes, breathing becomes rapid, and muscles tense up," explains Dr Shobha Sharma, consultant psychologist at Yashoda Super Speciality Hospital, Ghaziabad.
Mentally, people may experience heightened alertness or paradoxical calm. 'People may experience racing thoughts, tunnel vision, or even a strange sense of calm or detachment. Time can feel like it slows down."
Dr Rajul Aggarwal, director, neurology, at Delhi-based Sri Balaji Action Medical Institute, explained that at such a point, the body is wracked with sheer fear and adrenaline. 'The reality is that in a high-impact scenario, the brain does not have the time to process the feeling of pain or fear for long."
Do victims remain conscious?/strong>
When the aircraft hits, the brain suffers severe physical trauma. The result or consequence depends on the speed and angle of the impact, the location of the individual in the aircraft and whether the individual was wearing any protective equipment, such as seatbelts.
'The brain is considered very vulnerable, and in a sudden impact of violent deceleration, there is a possibility that the brain can slam against the skull, causing a very serious injury to the health of an individual, such as diffuse axonal injury or many others," Aggarwal added.
According to Dr Dhavapalani Alagappan, head, emergency response department at Apollo Hospitals, Chennai, there are high chances that the majority of people would have lost consciousness before the plane caught fire. 'The height and speed would cause huge trauma to the brain and other parts of the human body. The impact on the head would have been massive. A small proportion of people could have been aware till the last moment, but otherwise, many would have already lost their senses."
Explaining this scientifically, Dr Anandh Balasubramaniam, senior consultant, head of department, neurosurgery, at Faridabad-based Amrita Hospital said, 'Severe deceleration during a crash causes abrupt violence to internal organs. … diffuse axonal injury—where neurons shear torn due to momentum differentials."
However, the real scenario depends on crash dynamics. 'In cases of gradual decompression—like MH17 —victims may remain conscious during descent until impact. Similarly, rapid cabin depressurisation can cause loss of consciousness within seconds due to sudden hypoxia."
Advertisement
Dr Balasubramaniam was referring to Malaysia Airlines Flight MH17, which in 2014 was hit by a missile at high altitude, and investigators believe some passengers may have remained conscious during the long descent before the final impact. A similar case was with Air France Flight 447 in 2009. In this case, the aircraft stalled mid-air and took over three minutes to descend, suggesting the possibility that passengers were aware during the fall, intensifying psychological trauma.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
35 minutes ago
- The Hindu
Health matters newsletter: The whole truth about weight-loss drugs
On 'weight loss' drugs and their impacts, the scorching heat and sleep apnoea, what persists after a Covid-19 infection, AI in healthcare, and more. Universally, a certain class of drugs have come to be superstars in recent times. The GLP-1 class of drugs, with their capacity for weight loss, though originally conceived and developed for diabetes, has suddenly become the toast of the season, for one reason - their weight loss properties. With celebrities like Elon Musk flaunting their use of these drugs, semaglutide and more recently, tirzepatide, reached homes even before the results of rigorous control trials were ready for publication. While over the months, the trials have indicated good overall results, both for weight loss and blood sugar control, a new field study offers a more realistic estimate of how these GLP-1 receptor agonists work in real time. A recent study, done in the U.S. indicated that these New 'weight-loss' drugs have lower impact in real life compared to clinical trial results. In a paper published in the journal Obesity, Hamlet Gasoyan et al accessed electronic health record data from a large health system in Ohio and Florida to identify adults with overweight or obesity without type 2 diabetes who started with injectable semaglutide or tirzepatide between 2021 and 2023. The researchers observed that treatment discontinuation and use of lower maintenance dosages might reduce the likelihood of achieving clinically-meaningful weight reduction in patients on these drugs. This is something that diabetologists in India agreed with, instinctively. In a randomised control trial, there is incentive and constant reminders to take the drugs. In the real world setting, when patients have to pay for their drugs out of their own pocket and without a rigorous reminder, or because of the side effects that they cannot tolerate, a number of people discontinue treatment. And drugs work only as long as they are taken. Further on this topic, Dr. V. Mohan, Chennai-based diabetologist discusses on The Health Wrap by The Hindu about who are ideal candidates for these drugs, whether a regimen must be followed and deciding the appropriate dosage levels for people on GLP-1 drugs. Zubeda Hamid and I discuss other issues too, including good and bad bacteria, migration and climate change, not to mention a giraffe's cervical structure. Do tune in, to listen. Having lived out another May, a torrid summer, there is no doubt that a climate crisis is upon us. The WHO says 2024 was the warmest year on record – but the heat is far from over. A new report from the World Meteorological Organization (WMO) warns that global temperatures will likely continue rising, with an 80 per cent chance that at least one year between now and 2029 will be even hotter. Climate emergency is a health crisis 'that is already killing us,' the WHO adds. Delhi and other parts of northern and central India were severely impacted as temperatures soared beyond bearable. Our stories give you a clear picture: Delhi under 'red alert' as mercury soars beyond 45 degrees C; severe heatwave conditions to persist; Blistering heat continues in north, central India; hills scorch. Meanwhile, we also reported on a study which found that Warmer climate could make sleep apnoea more severe, common. Sleep apnoea, a condition characterised by having trouble breathing properly while sleeping, could become more common and severe in a warmer future, a new study has found. Obstructive Sleep Apnoea (OSA) is a common sleep disorder, estimated to affect about a billion worldwide. The condition occurs when muscles in the throat narrow the airways, impacting breathing and blood oxygen levels during findings, published in the journal Nature Communications, show that one's chances of experiencing sleep apnoea could spike by 45 per cent on days with higher temperatures. Meanwhile, the government is mulling whether to restrict the temperature range on air conditioners. Vasudevan Mukunth, here, explains the Science behind setting the right temperature on the air conditioner. Last week, a very important document was launched, something we would do well to heed. With the launch of HelpAge India's national report, ahead of World Elder Abuse Awareness Day, which is marked on June 15, on intergenerational dynamics, it is clear that we need to create better bonds with senior citizens and also encourage more digital literacy. For a greying nation, we need to pay more attention to the health and social support needs of the elderly, bringing it back into the DNA of the culture we live in. We do our periodic dip stick test for COVID-19, profiling various developments in the area, even as the number of cases is going up slowly. Dr. M.S. Seshadri and Dr. T. Jacob John explain what the current Resurgence of COVID 19 means for India. They argue that the recent number of COVID-19 cases, reported as nearly 7,000, reflects the greater volume of testing, not the true magnitude of infection or disease in the population. More than four years since the COVID-19 pandemic began, the disease remains a global health concern — not because of new surges but because of what persists. Do read about a genetics study that linked a lung gene to known, recorded post-COVID sequelae. Bindu Shajan Perappadan also focuses on the same angle, reminding readers of the the threat of deep vein thrombosis associated with COVID. We also endeavour to point out areas of hope and positivity, as it is so important in health care. Health is as much about wellness and recovery as it is about disease and pain. There is some hope with reports that Novavax's COVID-flu combo vaccine which showed strong immune response in trial. In other news, Jacob Koshy reports that SII and DNDi have partnered to expand human trials for dengue treatment. Hopefully, we will have better dengue treatment protocols soon. Again in India, here is a model that could be replicated, as Rajasthan's cash plus model pushes up early breastfeeding rate, dietary diversity among new mothers. The big minus about treating cancer is the way the treatment causes general toxicity, as it tars even healthy tissue with the same brush. Here, there seems to be a solution to this: In a first, arc therapy beats tricky cancer while sparing nearby tissue. Afshan Yasmeen reported that Karnataka's MMR was steadily decline; it has reduced to 58 per lakh live births in 2020-22. Great news, indeed. It was also the week we discussed India's falling fertility rates. As per a UN report, fertility rate drops below replacement level, Purnima Sah wrote. According to the UNFPA, millions of people in India are not able to realise their real fertility goals. Calling this the 'real' crisis, and not overpopulation or underpopulation, the report calls for the pursuit of reproductive agency — a person's ability to make free and informed choices about sex, contraception and starting a family — in a changing world. Replacement-level fertility, commonly defined as 2.1 births per woman, is the rate at which a population size remains constant from one generation to the next. The recent World Health Assembly has created a turning point for skin health, explained Dr. Monisha Madhumitha. Here's what the WHA's landmark resolution on skin diseases means for the world. Moving on to a key component of health care, we had articles that discussed the role of AI in the health sector this past week. While Sayantan Datta asked How safe AI is in healthcare depends on the humans of healthcare, Dr. Aravinda C. took the argument further discussing the promise and pitfalls of evaluating AI tools with mismatched yardsticks. Dr. V. Viju Wilben turned our attention to how technology can help, at a time when most city roads are perennially clogged with traffic jams, to reclaim the Golden Hour, and save lives. In the tailpiece segment, reverse ageing steals the spotlight. If only it were possible! But Anirban Mukhopadhyay brought hope, with the article. Common molecule offers clue to making old muscles young again. As we age, it gets harder to recover from a fall, injury or even a tough workout because the body's muscle-repair system starts to falter. Muscle stem cells (MuSCs), the in-house repair crew, stop dividing and rebuilding tissue, losing their ability to respond to damage. A study in Cell Stem Cell on June 12 suggested this decline may be reversible. The key isn't some futuristic therapy but a molecule already used in hospitals today -prostaglandin E2. We had a very healthy, and robust explainers section this week. Sophie Davies, in The Conversation wrote of Diverticular disease Sreedevi Jayachandran explained Tourette syndrome and its management Serena Josephine M.'s story in our 'All You Need to Know About' series was on hernias Dr. Steve Thomas wrote two fine pieces on the occasion of blood donation day. Do click on the links to read them: Our body's crimson tide: understanding blood disorders and the vital role of blood donation and Our body's crimson tide: the evolving treatment landscape in haematology Athira Elssa Johnson wrote on The risks of undiagnosed gall bladder stones: doctors call for awareness, timely treatment, how to read the tongue as a measure of health; and filed yet another story in our monthly Nobel winners series: This one on Sir Ronald Ross and his contributions towards malaria control Dr. Sathyanarayana L.D. elaborated on a little-explored subject, in connection with Brain Tumour Day (June 8) on aphasia, or the loss of language, after brain tumour surgery. Our In Focus podcast discussed the risks of the government's proposed 'mixopathy' move If you have some extra time on your hands, also read: C. Maya: Living donor transplants thrive as Kerala turns its face away from deceased donor organ donations Serena Josephine M.: Many private hospitals in T.N. hit by acute shortage of Hepatitis B vaccine Indian-origin physician Bobby Mukkamala sworn in as American Medical Association president Science Quiz: On eye health – For many more health stories, head to our health page and subscribe to the health newsletter here.
The Hindu
2 hours ago
- The Hindu
DRDO, IIT-Delhi demonstrate free-space quantum secure communication over 1 km
Defence Research and Development Organisation (DRDO)-Industry-Academia Centre of Excellence (DIA-CoE) at IIT Delhi has demonstrated free-space quantum secure communication using quantum entanglement over a distance of more than one km via an optical link. The development is being considered a key breakthrough in the field of cybersecurity. Defence Minister Rajnath Singh has congratulated DRDO and IIT-Delhi, describing it as a landmark achievement showcasing India's entry into a new quantum era of secure communication, 'which will be a game changer in future warfare'. The experiment, conducted on IIT-Delhi campus, attained a secure key rate of nearly 240 bits per second with a quantum bit error rate of less than 7%. 'This entanglement-assisted quantum secure communication paves the way for real-time applications in quantum cybersecurity, including long-distance Quantum Key Distribution (QKD), the development of quantum networks, and the future quantum internet,' said the Defence Ministry. Stating that the efforts aligned with India's broader objectives to advance quantum technologies for national development, the Ministry said under the project 'Design and development of photonic technologies for free space QKD', sanctioned by the Directorate of Futuristic Technology Management of DRDO, the demonstration was given by Prof. Bhaskar Kanseri's research group in the presence of several dignitaries. 'Quantum entanglement-based QKD offers several significant advantages over the traditional prepare-and-measure method by enhancing both security and functionality. Even if devices are compromised or imperfect, the use of quantum entanglement ensures the security of key distribution. Any attempt to measure or intercept the entangled photons disturbs the quantum state, allowing authorised users to detect the presence of an eavesdropper,' it said. The Ministry said quantum communication provided fundamentally unbreakable encryption, making it a dual-use technology with applications in securing data in strategic sectors such as defence, finance, and telecommunications, as well as in protecting national security-related communications. 'Free-space QKD eliminates the need to lay optical fibres, which can be both disruptive and expensive, especially in challenging terrains and dense urban environments,' the Ministry said. Earlier, India's first intercity quantum communication link between Vindhyachal and Prayagraj in 2022, using commercial-grade underground dark optical fibre was demonstrated by DRDO scientists along with Prof. Bhaskar's team. In 2024, the team successfully distributed quantum keys using entanglement over a 100-km spool of telecom-grade optical fibre in another DRDO-supported project. These technologies are being developed through DIA-CoEs, 15 of which have been established at premier academic institutes like IITs, IISc, and universities.
Fibre2Fashion
2 hours ago
- Fibre2Fashion
Veranova invests $50 mn+ in ADC bioconjugation at Devens
Veranova, a global leader in the development and manufacturing of specialist and complex active pharmaceutical ingredients (APIs) for the pharmaceutical and biotech sectors, today announced a strategic investment to establish state-of-the-art bioconjugation development and cGMP manufacturing capacity at its Devens, Massachusetts campus. Veranova is investing over $50 million to add bioconjugation development and cGMP manufacturing at its Devens, MA site, creating up to 70 jobs. The expansion, set for June 2026, will support ADCs and other bioconjugates, addressing rising demand for US-based biomanufacturing. It builds on Devens' expertise in complex synthesis and linker-payload production. This expansion will enable Veranova to provide a more comprehensive suite of services to partners developing antibody-drug conjugates (ADCs) and other bioconjugates, and builds on the Devens facility's extensive experience in the development and clinical and commercial manufacture of ADC linker-payloads. Combined with a previously announced expansion of high-potent synthesis capacity in Devens, this will represent a more than $50 million investment into the site's capabilities for ADCs and other bioconjugates and will create up to 70 new jobs. The new capacity is planned to come online in June 2026. The investment also addresses increasing demand for strong U.S.-based biomanufacturing capabilities and will help U.S.-based customers secure domestic supply chains for critical drug substances. The bioconjugation expansion will include new process and analytical development laboratories, grade C cleanroom space, development and cGMP equipment and instrumentation, and supporting infrastructure. These capabilities will support up to kilogram-scale manufacturing of potent and non-potent bioconjugates. 'We continue to see ADCs and other conjugated molecules as a key growth area as our customers look to develop more targeted therapies,' said Mike Riley, CEO of Veranova. 'This investment will build on our core capabilities in complex chemistry, analytics and linker-payload synthesis, and leverage our strategically located cGMP infrastructure to provide a differentiated solution to our customers.' The Devens site is a key location in Veranova's global manufacturing network, situated in close proximity to the Boston-Cambridge biotechnology hub. The site has over 15 years of experience in the development and manufacture of linker-payloads and other complex synthetic molecules supported by expertise in complex synthesis, analytical development and testing, high potent handling, crystallization development, and chromatography purification. Veranova Devens is an FDA-approved facility with capabilities spanning early process and analytical development, scale-up, and clinical and commercial manufacturing under one roof. Note: The headline, insights, and image of this press release may have been refined by the Fibre2Fashion staff; the rest of the content remains unchanged. Fibre2Fashion News Desk (HU)
